Auph short interest.
Aurinia ( AUPH) shares have climbed ~59.7% in the year so far despite a ~2% decline over the past 30 days. The stock has added ~5.8% in the post-market with ~1.5M shares changing hands compared to ...
Cantor Fitzgerald Reiterates Aurinia Pharmaceuticals (AUPH) Overweight Recommendation. ... Highest Short Float; Owners Retail Ownership Most Popular Funds Activist Investors Fund Sentiment - World. United States Canada UK Hong Kong Japan Australia New Zealand.Short interest, stock short squeeze, short interest ratio & short selling data positions for NASDAQ, NYSE & AMEX stocks to find shorts in the stock market.Web22 votes, 16 comments. 1K subscribers in the AUPH community. A place to discuss Aurinia Pharmaceuticals, Inc.2 Nov 2023 ... The change is primarily related to change in fair value assumptions driven predominantly by rising interest ... Short-term investments. 291,503.Aurinia ( AUPH) shares have climbed ~59.7% in the year so far despite a ~2% decline over the past 30 days. The stock has added ~5.8% in the post-market with ~1.5M shares changing hands compared to ...
The Short Squeeze Score is the result of a sophisticated, multi-factor quantitative model that identifies companies that have the highest risk of experiencing a short squeeze. The scoring model uses a combination of short interest, float, short borrow fee rates, and other metrics. The number ranges from 0 to 100, with higher numbers indicating ...
The u/AnalystRipper community on Reddit. Reddit gives you the best of the internet in one place.
Short Interest. Most Shorted. Largest Increase. Largest Decrease. Calculators. Margin Calculator. ... Aurinia Pharmaceuticals (AUPH) is scheduled to report earnings on February 27, 2024.AUPH short interest is 12%. More on Aurinia. Aurinia Pharmaceuticals: Some Improvement In Topline, But A Buyout Alone Will Unlock Value; Aurinia Pharmaceuticals: All In On Lupkynis - A Tough Bet;A high-level overview of Aurinia Pharmaceuticals Inc. (AUPH) stock. Stay up to date on the latest stock price, chart, news, analysis, fundamentals, trading and investment tools. ... Short Interest ...Aurinia Pharmaceuticals Inc. (NASDAQ:AUPH – Get Free Report) (TSE:AUP) was the target of a large growth in short interest in July. As of July 15th, there was short interest totalling 16,710,000 shares, a growth of 6.8% from the June 30th total of 15,650,000 shares. Based on an average daily trading volume, of 2,430,000 shares, the […]Aurinia Pharmaceuticals (NASDAQ: AUPH) has filed a $250M mixed shelf offering. The filing does not necessarily indicate that a sale has begun, or will occur in the future. Shares are down 12% in ...
AUPH | Aurinia Pharmaceuticals short interest and earnings date annual report Jul, 2023 Mailing Address #1203-4464 MARKHAM STREET VICTORIA BC A1 V8Z 7X8. Business Address #1203-4464 MARKHAM STREET VICTORIA BC A1 V8Z 7X8 250-708-4272. SIC: 2834 - PHARMACEUTICAL PREPARATIONS. State location: A1 | State of Inc.: A0 | …
Thinking about investing in Aurinia Pharmaceuticals because of the upcoming earnings date annual report or stock price forecast? Check out AUPH short interest and earnings date annual report by comparing AUPH insider trading history and institutional ownership breakdown to maximise your investment return on the stock market.
Frequency Therapeutics (NASDAQ:FREQ – Get Rating) and Appili Therapeutics (OTCMKTS:APLIF – Get Rating) are both small-cap medical companies, but which is the superior business? We will compare the two companies based on the strength of their risk, valuation, earnings, dividends, institutional ownership, profitability and …WebShort Interest. Percentage of Shares Shorted 11.97% of the outstanding shares of Aurinia Pharmaceuticals have been sold short. Short Interest Ratio / Days to …Short Float / Ratio: 13.17% / 8.88: Perf Quarter-4.23%: Sales: 158.85M: P/S: 8.19: EPS this Y: 31.36%: Inst Trans: 9.16%: Short Interest: 17.19M: Perf Half Y-5.03%: Book/sh: 2.73: P/B: 3.32: EPS next Y: 29.71%: ROA-14.80%: Target Price: 13.21: Perf Year: 76.61%: Cash/sh: 2.35: P/C: 3.85: EPS next 5Y-ROE-18.94%: 52W Range: 4.07 - 12.43: Perf YTD ... Frequency Therapeutics (NASDAQ:FREQ – Get Rating) and Appili Therapeutics (OTCMKTS:APLIF – Get Rating) are both small-cap medical companies, but which is the superior business? We will compare the two companies based on the strength of their risk, valuation, earnings, dividends, institutional ownership, profitability and …WebAurinia Pharmaceuticals Inc. (NASDAQ:AUPH – Get Rating) (TSE:AUP) was the recipient of a large decline in short interest during the month of November. As of November 15th, there was short interest totalling 8,290,000 shares, a decline of 27.7% from the October 31st total of 11,460,000 shares.WebIn this section, we analyze the short-term loss avoidance of every unplanned, open-market insider sale made in AUPH / Aurinia Pharmaceuticals Inc. A consistent pattern of loss avoidance may suggest that future sale transactions may predict declines in price. On another thread there us a guy who is misguided and blaming mgmt. Claims short interest is going up. I checked itsv8.5% as of May 15th. We should soon find out if short interest has gone up.
Nov 17, 2023 · Aurinia Pharmaceuticals Inc. (NASDAQ:AUPH) Short Interest Down 16.4% in August marketbeat.com - September 17 at 6:15 AM: Here's Why We're Not At All Concerned With Aurinia Pharmaceuticals' (NASDAQ:AUPH) Cash Burn Situation finance.yahoo.com - September 11 at 9:56 AM Business, Economics, and Finance. GameStop Moderna Pfizer Johnson & Johnson AstraZeneca Walgreens Best Buy Novavax SpaceX Tesla. Crypto30 Mar 2023 ... ... AUPH stock is predictable in the short/long term. According to price ... If an entity originates a loan that bears an off-market interest ...Aurinia Pharma press release (NASDAQ:AUPH): Q2 GAAP EPS of -$0.08 beats by $0.11.; Revenue of $41.49M (+47.2% Y/Y) beats by $3.98M. Increases 2023 revenue guidance range to $150 - $160 million ...@PITX3 not really great short squeeze potential, more like short caress. 11% of float takes 5 - 6 days to cover. From mid-April to mid-May the short position decreased by 2M down to 15.5M, 11% of ...Aurinia Pharmaceuticals Stock (NASDAQ: AUPH) stock price, news, charts, stock research, profile. ... Profile News Analyst Ratings Guidance Dividends Earnings Insider Trades Ideas Short Interest. 0.Aurinia Pharmaceuticals (NASDAQ: AUPH) has filed a $250M mixed shelf offering. The filing does not necessarily indicate that a sale has begun, or will occur in the future. Shares are down 12% in ...
AUPH Earnings Date and Information. Aurinia Pharmaceuticals last issued its quarterly earnings data on November 2nd, 2023. The biotechnology company reported ($0.09) EPS for the quarter, topping analysts' consensus estimates of ($0.17) by $0.08. The company had revenue of $54.52 million for the quarter, compared to the consensus estimate of $38 ...Interest Coverage Financials. AUPH's profit margin has increased... subscribe to Premium to read more. Profit Margin Growth Financials. ... AUPH's cash and short-term investments... subscribe to Premium to read more. Debt Coverage Financials. AUPH vs Biotech Stocks. Ticker Market Cap 1d % P/E P/B; AUPH: $1.18B +4.44%-15.53x:
Aurinia Pharmaceuticals ( NASDAQ: AUPH) has been on a roll this year since their second quarter earnings in August. The stock jumped from $10 to over $30, buoyed by strong uptake of voclosporin ...AUPH - Short squeeze stock short interest data and short selling information for shares of Aurinia Pharmaceuticals Ord. Short interest stock data available for NASDAQ, NYSE, AMEX, OTCBB and Pink Sheets stocks available from shortsqueeze.com. Short interest, stock short squeeze, short interest ratio & short selling data positions for NASDAQ, NYSE & AMEX stocks to find shorts in the stock market.WebStock Market Quotes, Business News, Financial News, Trading Ideas, and Stock Research by Professionals.Nov 21, 2023 · Aurinia Pharmaceuticals ( NASDAQ: AUPH) soared 6.7% amid takeover speculation. The Aurinia ( AUPH) stock surge comes amid a report that a Gilead Sciences ( GILD) corporate jet made a trip to ... Aurinia Pharmaceuticals ( NASDAQ: AUPH) named Dr. Robert Foster as a new board member Thursday as part of an agreement with its major shareholder and investment management firm, MKT Capital Ltd ...
Dec 10, 2021 · Aurinia Pharmaceuticals (NASDAQ: AUPH) is trading ~2.5% higher in the pre-market after Oppenheimer raised its recommendation on the stock to Outperform from Perform. The price target of $31 per ...
Cash received for interest $ ... (Nasdaq) under the symbol AUPH. 2. Summary of Significant Accounting Policies . Basis of Presentation. ... September 2022, the fixed lease term ended on the Victoria lease and the Company exercised its right to enter into a short-term month to month lease, of which expenses are incurred in SG&A. ...
Aurinia Pharmaceuticals Inc. (NASDAQ:AUPH – Get Free Report) (TSE:AUP) was the target of a large growth in short interest in July. As of July 15th, there was short interest totalling 16,710,000 shares, a growth of 6.8% from the June 30th total of 15,650,000 shares. Based on an average daily trading volume, of 2,430,000 shares, the […]AUPH Earnings Date and Information. Aurinia Pharmaceuticals last issued its quarterly earnings data on November 2nd, 2023. The biotechnology company reported ($0.09) EPS for the quarter, topping analysts' consensus estimates of ($0.17) by $0.08. The company had revenue of $54.52 million for the quarter, compared to the consensus estimate of $38 ...Rumors are that they will pay at least 40 till 44 dollar. Earnings are coming sooner at the 3rd of November. But there is also a high SI. Some buying…Market Capitalization. $1.24 billion. P/E Ratio. N/A. Dividend Yield. N/A. Price Target. $14.00. Stock Analysis Analyst Forecasts Chart Competitors Earnings Financials Headlines Insider Trades Options Chain Ownership SEC Filings Short Interest Social Media.Loan debt generally consists of two parts: the principal, or the total amount of the loan, and interest, or the extra amount the lender charges as compensation for what you’ve borrowed.1K subscribers in the AUPH community. A place to discuss Aurinia Pharmaceuticals, Inc. Coins. 0 coins. Premium Powerups Explore Gaming. Valheim Genshin Impact Minecraft Pokimane Halo Infinite Call of Duty: Warzone Path of Exile Hollow Knight: Silksong Escape from Tarkov Watch Dogs: Legion. Sports ...Aurinia Pharmaceuticals Stock (NASDAQ: AUPH) stock price, news, charts, stock research, ... Profile News Analyst Ratings Guidance Dividends Earnings Insider Trades Ideas …Initially, Lupkynis seemed to be a promising treatment for LN, but its adoption has fallen short of expectations, as shown by Aurinia's failure to meet its 2022 revenue projections ($115-$135 ...“The possibility of a short squeeze is one reason some analysts look at a high amount of short interest as a bullish indicator. Short Interest is the fuel, performance is the fuse, says ShortSqueeze.com” - USA Today ...short sellers, not financial results, are driving up …
2 Nov 2023 ... The change is primarily related to change in fair value assumptions driven predominantly by rising interest ... Short-term investments. 291,503.Nov 2, 2023 · Interest income was $4.5 million at September 30, 2023 versus $1.5 million for the prior year period. Interest income was $12.4 million and $2.2 million for the nine months ended September 30 ... Some thoughts on AUPH: 1. As cited, AUPH reported Lupkynis sales +46% YOY, +20% over Q1, and raised full year guidance to $150 million - $160 million, but admittedly is only scratching the surface ...Instagram:https://instagram. banks with virtual debit cardcashapp investw nysebest charting software for futures trading Short Interest. Prev. Close. Compare to Peers. More on AUPH. Trending Analysis. Trending News. Seeking Alpha - Power to Investors. Power to Investors. Follow us. Download app. Subscription Support ... lwaybest retirement planning software 2023 for individuals Aurinia Pharmaceuticals Inc Ordinary Shares (AUPH) Stock Quotes - Nasdaq offers stock quotes & market activity data for US and global markets.586. -18.84. 2023-11-22. NP. PSGIX - Blackrock Advantage Small Cap Growth Fund Institutional This fund is a listed as child fund of BlackRock Inc. and if that institution has disclosed ownership in this security, then these positions will not be double counted when calculating total shares and total value. s and p history chart 2021-12-28 Short sale volume (not short interest) for $FSR is 66%. http://shortvolumes.com/?t=FSR $KDP 44% $TNA 40% $SPDW 77% $AUPH 41%. 29 Dec 2021WebAurinia ( AUPH) shares have climbed ~59.7% in the year so far despite a ~2% decline over the past 30 days. The stock has added ~5.8% in the post-market with ~1.5M shares changing hands compared to ...